2022 annual financial data
Anixa Biosciences 2022 Operating margin
Anixa Biosciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was -0.56%.
Operating income was -13,875,000 USD and net income was -13,595,000 USD.
Operating cash flow was -6,492,000 USD.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,469,000,000 USD
- Operating income
- -13,875,000 USD
- Net income
- -13,595,000 USD
- Operating cash flow
- -6,492,000 USD